4//SEC Filing
REGENERON PHARMACEUTICALS INC 4
Accession 0001237899-16-000085
$REGNCIK 0000872589operating
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 5:41 PM ET
Size
16.0 KB
Accession
0001237899-16-000085
Insider Transaction Report
Form 4
BAKER CHARLES A
Director
Transactions
- Sale
Common Stock
2016-12-12$390.67/sh−600$234,402→ 11,400 total - Sale
Common Stock
2016-12-12$394.33/sh−200$78,866→ 9,000 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2016-12-12−3,000→ 2,000 totalExercise: $18.61Exp: 2019-01-02→ Common Stock (3,000 underlying) - Sale
Common Stock
2016-12-12$393.64/sh−600$236,184→ 9,200 total - Exercise/Conversion
Common Stock
2016-12-12$18.61/sh+3,000$55,830→ 12,000 total - Sale
Common Stock
2016-12-12$391.36/sh−1,200$469,632→ 10,200 total - Sale
Common Stock
2016-12-12$392.41/sh−400$156,964→ 9,800 total
Footnotes (7)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]Represents volume-weighted average price of sales of 600 shares of Company stock on December 12, 2016 at prices ranging from $390.26 to $390.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 12, 2016 at each separate price.
- [F3]Represents volume-weighted average price of sales of 1,200 shares of Company stock on December 12, 2016 at prices ranging from $391.02 to $391.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 12, 2016 at each separate price.
- [F4]Represents volume-weighted average price of sales of 400 shares of Company stock on December 12, 2016 at prices ranging from $392.00 to $392.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 12, 2016 at each separate price.
- [F5]Represents volume-weighted average price of sales of 600 shares of Company stock on December 12, 2016 at prices ranging from $393.39 to $393.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 12, 2016 at each separate price.
- [F6]Represents volume-weighted average price of sales of 200 shares of Company stock on December 12, 2016 at prices ranging from $394.24 to $ 394.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 12, 2016 at each separate price.
- [F7]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS INC
CIK 0000872589
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000872589
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 5:41 PM ET
- Size
- 16.0 KB